AIM WINNERS & LOSERS: Rockfire Resources hails Molaoi resource upgrade

(Alliance News) - The following stocks are the leading risers and fallers on AIM on ...

Alliance News 4 September, 2024 | 10:06AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.

----------

AIM - WINNERS

----------

Rockfire Resources PLC, up 33% at 0.24 pence, 12-month range 0.10p-0.40p. The Greece and Australia-focused gold, base metal and critical mineral exploration company's shares jumped, after announcing a six-fold mineral resource upgrade at Molaoi. Located in Greece, Molaoi is a zinc, silver, and lead deposit. The inferred resource estimate is now 15.0 million tonnes at 7.3% zinc, 1.8% lead, and 39.5 grams per tonne of silver. This compares to a maiden resource estimate from May 2022 of 2.3 million tonnes at 11% zinc equivalent, for 250,000 tonnes of zinc equivalent. Rockfire Resources said that the new resource has "surpassed all expectations", and places Molaoi "within the top 20 undeveloped zinc resources globally in terms of tonnage, grade and zinc equivalent metal content".

----------

AIM - LOSERS

----------

Shield Therapeutics PLC, down 9.8% at 4.78p, 12-month range 1.06p-12.85p. The Newcastle, England-based commercial-stage pharmaceutical company reports a pretax loss for the six months ended June 30 of USD15.5 million, widening from USD11.8 million a year prior. This was despite an improvement in revenue, which increases to USD12.1 million from USD3.7 million. Shield said that losses were in part driven by the expansion of a US field force supporting the launch of Accrufer, its iron deficiency medication.

----------

By Holly Beveridge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Rockfire Resources PLC 0.10 GBX 1.95 -
Shield Therapeutics PLC 4.19 GBX 2.20 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures